These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Preoperative evaluation of patients with cardiovascular disorders]. Todokoro S Masui; 1999; 48 Suppl():S117-25. PubMed ID: 10785970 [No Abstract] [Full Text] [Related]
6. Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery (Br J Surg 2005; 92: 1041-1045). Gibson S; Berry C; Kingsmore D Br J Surg; 2005 Nov; 92(11):1453-4. PubMed ID: 16237747 [No Abstract] [Full Text] [Related]
7. Rationale for testing the cardiovascular risk for patients with COX-2 inhibitors on the basis of biomarker NT-proBNP. Giannitsis E Clin Lab; 2005; 51(1-2):63-83. PubMed ID: 15719708 [TBL] [Abstract][Full Text] [Related]
8. Biomarker sensitivity and specificity require pre-test probability of disease diagnosis to be collated: additional points on the interpretation of pro-B-type natriuretic peptide triage of dyspnea in the Copenhagen Heart Study. MacFadyen RJ; Chuen MJ J Am Coll Cardiol; 2008 Apr; 51(13):1322-3; author reply 1323. PubMed ID: 18371568 [No Abstract] [Full Text] [Related]
9. Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T. Sommerer C; Giannitsis E; Schwenger V; Zeier M Nephron Clin Pract; 2007; 107(3):c77-81. PubMed ID: 17890874 [TBL] [Abstract][Full Text] [Related]
10. Natriuretic peptides in heart failure: their role in daily practice. Loboz-Grudzień K; Jaroch J Cardiol J; 2009; 16(1):1-3. PubMed ID: 19130409 [No Abstract] [Full Text] [Related]
15. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease. Hess G; Runkel S; Zdunek D; Hitzler WE Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172 [TBL] [Abstract][Full Text] [Related]
16. Use of cardiac biomarkers in end-stage renal disease. Wang AY; Lai KN J Am Soc Nephrol; 2008 Sep; 19(9):1643-52. PubMed ID: 18322158 [TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007 [TBL] [Abstract][Full Text] [Related]
18. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Schnabel R; Rupprecht HJ; Lackner KJ; Lubos E; Bickel C; Meyer J; Münzel T; Cambien F; Tiret L; Blankenberg S; Eur Heart J; 2005 Feb; 26(3):241-9. PubMed ID: 15618051 [TBL] [Abstract][Full Text] [Related]
19. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide. Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049 [TBL] [Abstract][Full Text] [Related]
20. Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery (Br J Surg 2005; 92: 1041-1045). Brady RR; Ryan M Br J Surg; 2005 Dec; 92(12):1566; author reply 1566. PubMed ID: 16308866 [No Abstract] [Full Text] [Related] [Next] [New Search]